3D Printing Supports Accurate Radiation Therapy Delivery
By MedImaging International staff writers Posted on 08 Jul 2015 |
Image: Example of bolus printed to conform to the nose of a phantom (Photo courtesy of Stony Brook Medicine).
A new study demonstrates how an inexpensive three dimensional (3-D) printer can be used to manufacture a patient-specific bolus for external beam therapy.
Researchers at Stony Brook Medicine (NY, USA) conducted a project to design and print a bolus using a treatment planning system and an inexpensive (USD 3,000) 3-D printer. The bolus is a device used in radiation therapy (RT) placed directly on the patient’s skin, and is intended to shape the desired RT dose to surface anatomy, thus conforming and containing the planning target volume (PTV) dose while delivering minimal radiation to adjacent underlying critical structures and normal tissues.
The researchers began the design process using a phantom as the test subject. After a computerized tomography (CT) scan was acquired, the data was exported to the Varian (Palo Alto, CA, USA) Eclipse treatment planning system. Once a satisfactory bolus design was determined, the structure set was exported to 3DSlicer, a 3-D modeling software that is maintained as open source. The stereolithography (STL) files were interpreted by printer software, and instructions were sent to an Airwolf (Costa Mesa, CA, USA) 3-D printer.
The researchers tested different materials—including acrylonitrile butadiene styrene and polylactic acid—as the substrate. Dose plane comparisons were conducted for each material using the phantom model and photographic film to verify accurate treatment planning. They were also able to verify accurate treatment planning using gamma analysis, and found that with gamma criteria of 5% dose difference and 3 mm distance-to-agreement (DTA) leeway, they achieved 95% points passing. The study was published in the May-June 2015 issue of the Journal of Applied Clinical Medical Physics (JACMP).
“We are confident that we can accurately model this printing material in our treatment planning system for all energies in photon and electron beams,” concluded lead author Sarah Burleso, PhD, and colleagues of the department of radiation oncology. “In the event the patient cannot have bolus materials placed on their skin for molding, we can print a 3D positive mold of the patient’s treatment area, molding the bolus to the replica instead. This process of printing our own bolus streamlines patient care, minimizes patient involvement, and maintains quality treatments.”
Related Links:
Stony Brook Medicine
Varian
3DSlicer
Researchers at Stony Brook Medicine (NY, USA) conducted a project to design and print a bolus using a treatment planning system and an inexpensive (USD 3,000) 3-D printer. The bolus is a device used in radiation therapy (RT) placed directly on the patient’s skin, and is intended to shape the desired RT dose to surface anatomy, thus conforming and containing the planning target volume (PTV) dose while delivering minimal radiation to adjacent underlying critical structures and normal tissues.
The researchers began the design process using a phantom as the test subject. After a computerized tomography (CT) scan was acquired, the data was exported to the Varian (Palo Alto, CA, USA) Eclipse treatment planning system. Once a satisfactory bolus design was determined, the structure set was exported to 3DSlicer, a 3-D modeling software that is maintained as open source. The stereolithography (STL) files were interpreted by printer software, and instructions were sent to an Airwolf (Costa Mesa, CA, USA) 3-D printer.
The researchers tested different materials—including acrylonitrile butadiene styrene and polylactic acid—as the substrate. Dose plane comparisons were conducted for each material using the phantom model and photographic film to verify accurate treatment planning. They were also able to verify accurate treatment planning using gamma analysis, and found that with gamma criteria of 5% dose difference and 3 mm distance-to-agreement (DTA) leeway, they achieved 95% points passing. The study was published in the May-June 2015 issue of the Journal of Applied Clinical Medical Physics (JACMP).
“We are confident that we can accurately model this printing material in our treatment planning system for all energies in photon and electron beams,” concluded lead author Sarah Burleso, PhD, and colleagues of the department of radiation oncology. “In the event the patient cannot have bolus materials placed on their skin for molding, we can print a 3D positive mold of the patient’s treatment area, molding the bolus to the replica instead. This process of printing our own bolus streamlines patient care, minimizes patient involvement, and maintains quality treatments.”
Related Links:
Stony Brook Medicine
Varian
3DSlicer
Latest Nuclear Medicine News
- New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment